Electronic Patient Records to Identify Patients in the United Kingdom with Diabetic Macular Oedema Suitable for ILUVIEN(®) (Fluocinolone Acetonide)

INTRODUCTION: We describe a proactive method using electronic patient records (EPR) to identify pseudophakic patients with diabetic macular oedema (DMO) that might benefit from treatment with 0.2 µg/day fluocinolone acetonide (FAc; ILUVIEN(®)) implant. METHODS: Our EPR audit tool (Medisoft(®)) ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Farhat, Khan, Kamron, Chaudhry, Saadia, Khan, Rehna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909680/
https://www.ncbi.nlm.nih.gov/pubmed/27192988
http://dx.doi.org/10.1007/s40123-016-0053-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909680/
https://www.ncbi.nlm.nih.gov/pubmed/27192988
http://dx.doi.org/10.1007/s40123-016-0053-7

Ejemplares similares